Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


05.06.2017

3 Am J Obstet Gynecol
1 Br J Cancer
1 Cancer
16 Gynecol Oncol
1 Int J Oncol
1 Lancet Oncol
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. PETRILLO M, Marchetti C, De Leo R, Musella A, et al
    Brca Mutational Status, Initial Disease Presentation and Clinical Outcome in High-Grade Serous Advanced Ovarian Cancer: A Multicenter Study.
    Am J Obstet Gynecol. 2017 May 23. pii: S0002-9378(17)30647.
    PubMed     Text format     Abstract available

  2. BINDER PS, Peipert JF, Kallogjeri D, Brooks RA, et al
    Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Am J Obstet Gynecol. 2016 Jul 22. pii: S0002-9378(16)30470.
    PubMed     Text format     Abstract available

  3. FRANCHI D, Boveri S, Radice D, Portuesi R, et al
    Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for Borderline Ovarian tumors.
    Am J Obstet Gynecol. 2016 Jul 18. pii: S0002-9378(16)30458.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. VAN DER PUTTEN LJ, Visser NC, van de Vijver K, Santacana M, et al
    L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
    Br J Cancer. 2016 Aug 9. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    Cancer

  5. GANESH K, Shah RH, Vakiani E, Nash GM, et al
    Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30424.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  6. GUELI ALLETTI S, Petrillo M, Vizzielli G, Bottoni C, et al
    Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study.
    Gynecol Oncol. 2016 Oct 18. pii: S0090-8258(16)31491.
    PubMed     Text format     Abstract available

  7. BAI H, Cao D, Yuan F, Sha G, et al
    Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
    Gynecol Oncol. 2016 Oct 13. pii: S0090-8258(16)31481.
    PubMed     Text format     Abstract available

  8. SOLIMAN PT, Zhang Q, Broaddus RR, Westin SN, et al
    Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
    Gynecol Oncol. 2016 Oct 13. pii: S0090-8258(16)31483.
    PubMed     Text format     Abstract available

  9. FADER AN, Java J, Tenney M, Ricci S, et al
    Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
    Gynecol Oncol. 2016 Oct 12. pii: S0090-8258(16)31490.
    PubMed     Text format     Abstract available

  10. BRYK S, Farkkila A, Butzow R, Leminen A, et al
    Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
    Gynecol Oncol. 2016 Oct 8. pii: S0090-8258(16)31473.
    PubMed     Text format     Abstract available

  11. MISHKIN G, Minasian LM, Kohn EC, Noone AM, et al
    The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Gynecol Oncol. 2016 Sep 30. pii: S0090-8258(16)31432.
    PubMed     Text format     Abstract available

  12. AL-NIAIMI A, Dickson EL, Albertin C, Karnowski J, et al
    The impact of perioperative beta blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.
    Gynecol Oncol. 2016 Sep 29. pii: S0090-8258(16)31425.
    PubMed     Text format     Abstract available

  13. LEBLANC E, Narducci F, Bresson L, Hudry D, et al
    Fluorescence-assisted sentinel (SND) and pelvic node dissections by single-port transvaginal laparoscopic surgery, for the management of an endometrial carcinoma (EC) in an elderly obese patient.
    Gynecol Oncol. 2016 Oct 13. pii: S0090-8258(16)31482.
    PubMed     Text format     Abstract available

  14. SEAGLE BL, Dayno M, Strohl AE, Graves S, et al
    Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Gynecol Oncol. 2016 Oct 16. pii: S0090-8258(16)31495.
    PubMed     Text format     Abstract available

  15. HAGEN B, Valla M, Aune G, Ravlo M, et al
    Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Gynecol Oncol. 2016 Oct 21. pii: S0090-8258(16)31506.
    PubMed     Text format     Abstract available

  16. DAHM-KAHLER P, Borgfeldt C, Holmberg E, Staf C, et al
    Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Gynecol Oncol. 2016 Nov 3. pii: S0090-8258(16)31516.
    PubMed     Text format     Abstract available

  17. HANNIBAL CG, Vang R, Junge J, Frederiksen K, et al
    A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
    Gynecol Oncol. 2016 Nov 8. pii: S0090-8258(16)31563.
    PubMed     Text format     Abstract available

  18. HALTIA UM, Hallamaa M, Tapper J, Hynninen J, et al
    Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Mullerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Gynecol Oncol. 2016 Nov 18. pii: S0090-8258(16)31574.
    PubMed     Text format     Abstract available

  19. CHENG A, Li M, Kanis MJ, Xu Y, et al
    Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis.
    Gynecol Oncol. 2016 Nov 23. pii: S0090-8258(16)31518.
    PubMed     Text format     Abstract available

  20. JAMIESON A, Sykes P, Eva L, Bergzoll C, et al
    Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
    Gynecol Oncol. 2017 May 23. pii: S0090-8258(17)30879.
    PubMed     Text format     Abstract available

  21. WILBUR MB, Mannschreck DB, Angarita AM, Matsuno RK, et al
    Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Gynecol Oncol. 2016 Sep 21. pii: S0090-8258(16)31426.
    PubMed     Text format     Abstract available


    Int J Oncol

  22. LI X, Jin Y, Mu Z, Chen W, et al
    MicroRNA146a5p enhances cisplatininduced apoptosis in ovarian cancer cells by targeting multiple antiapoptotic genes.
    Int J Oncol. 2017 May 29. doi: 10.3892/ijo.2017.4023.
    PubMed     Text format     Abstract available


    Lancet Oncol

  23. SHAIKH F, Murray MJ, Amatruda JF, Coleman N, et al
    Paediatric extracranial germ-cell tumours.
    Lancet Oncol. 2016;17:e149-62.
    PubMed     Text format     Abstract available


    Oncol Rep

  24. CAO S, Chen C, Xue J, Huang Y, et al
    Silencing of type Igamma phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion.
    Oncol Rep. 2017 May 25. doi: 10.3892/or.2017.5670.
    PubMed     Text format     Abstract available


    PLoS One


  25. Correction: Blood type, ABO genetic variants, and ovarian cancer survival.
    PLoS One. 2017;12:e0178965.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: